Glezer Eli N. 4
4 · Singular Genomics Systems, Inc. · Filed May 13, 2024
Insider Transaction Report
Form 4
Glezer Eli N.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-05-09−15,000→ 225,000 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2024-05-09+15,000→ 4,600,000 total
Footnotes (3)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs vest in 16 equal quarterly installments over four years measured from February 9, 2024.